Mauna Kea Technologies (XPAR:ALMKT) Gross-Profit-to-Asset % : 20.00% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Mauna Kea Technologies's annualized Gross Profit for the quarter that ended in Dec. 2023 was €4.72 Mil. Mauna Kea Technologies's average Total Assets over the quarter that ended in Dec. 2023 was €23.59 Mil. Therefore, Mauna Kea Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 20.00%.

Mauna Kea Technologies Gross-Profit-to-Asset % Historical Data

The historical data trend for Mauna Kea Technologies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Gross-Profit-to-Asset % Chart

Mauna Kea Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

22.47

19.80

25.18

24.58

39.13

Mauna Kea Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															32.98	23.65	32.41	54.52	20.00

Competitive Comparison of Mauna Kea Technologies's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Mauna Kea Technologies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mauna Kea Technologies's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Gross-Profit-to-Asset % falls into.

Mauna Kea Technologies Gross-Profit-to-Asset % Calculation

Mauna Kea Technologies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	8.361	/	( (19.793	+	22.938)	/ 2 )
	=	8.361	/	21.3655
	=	39.13 %

Mauna Kea Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	4.718	/	( (24.241	+	22.938)	/ 2 )
	=	4.718	/	23.5895
	=	20.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Mauna Kea Technologies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mauna Kea Technologies (XPAR:ALMKT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (XPAR:ALMKT) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

1MK:Germany

Address

9, rue d'Enghien, Paris, FRA, 75010

Website

https://www.maunakeatech.com

Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (XPAR:ALMKT) Headlines

No Headlines